These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20768664)

  • 21. Contact sensitivity to proflavine.
    Goh CL
    Int J Dermatol; 1986 Sep; 25(7):449-51. PubMed ID: 3771042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Proflavine and Acriflavine in a Throat and Nose Department.
    Young G; Charteris AA
    Br Med J; 1940 Oct; 2(4162):489. PubMed ID: 20783338
    [No Abstract]   [Full Text] [Related]  

  • 23. Proflavine and acriflavine.
    Browning CH
    Br Med J; 1967 Apr; 2(5544):111. PubMed ID: 6020842
    [No Abstract]   [Full Text] [Related]  

  • 24. A theoretical study of acriflavin-DNA binding.
    Sanyal NK; Roychoudhury M; Tiwari SN; Ruhela KR
    Indian J Biochem Biophys; 1990 Aug; 27(4):213-8. PubMed ID: 2286385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment.
    Nehme R; Hallal R; El Dor M; Kobeissy F; Gouilleux F; Mazurier F; Zibara K
    Curr Med Chem; 2021; 28(11):2218-2233. PubMed ID: 32900342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ozonation of mutagenic and carcinogenic polyaromatic amines and polyaromatic hydrocarbons in water.
    Burleson GR; Caulfield MJ; Pollard M
    Cancer Res; 1979 Jun; 39(6 Pt 1):2149-54. PubMed ID: 109190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and metabolism of acriflavine in rats following intravenous or intramuscular administration of AG60, a mixture of acriflavine and guanosine, a potential antitumour agent.
    Song S; Kwon OS; Chung YB
    Xenobiotica; 2005 Jul; 35(7):755-73. PubMed ID: 16323364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of guanosine on the pharmacokinetics of acriflavine in rats following the administration of a 1:1 mixture of acriflavine and guanosine, a potential antitumor agent.
    Lee PS; Shin DH; Lee KM; Song S; Yoo HS; Moon DC; Hong JT; Chung YB
    Arch Pharm Res; 2007 Mar; 30(3):372-80. PubMed ID: 17424946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved acriflavine-Feulgen method.
    Levinson JW; Retzel S; McCormick JJ
    J Histochem Cytochem; 1977 May; 25(5):355-8. PubMed ID: 68068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of acriflavine and ineffectiveness of proflavine as immunosuppressant agents.
    Samuelson JS; Stewart PB; Kraft SC; Farr RS
    J Immunol; 1965 Aug; 95(2):314-22. PubMed ID: 5838754
    [No Abstract]   [Full Text] [Related]  

  • 31. THE CHEMOTHERAPY OF RECENT EXPERIMENTAL WOUND INFECTIONS: WITH SPECIAL REFERENCE TO THE ACTION OF ACRIFLAVINE.
    Browning CH; Gulbransen R
    Br Med J; 1925 Apr; 1(3354):688-90. PubMed ID: 20772003
    [No Abstract]   [Full Text] [Related]  

  • 32. THE FIXATION OF ANTISEPTICS BY DRESSINGS AND TISSUES: ITS IMPORTANCE IN WOUND TREATMENT, WITH SPECIAL REFERENCE TO ACRIFLAVINE.
    Graham JG
    Br Med J; 1928 Feb; 1(3500):173-4. PubMed ID: 20773668
    [No Abstract]   [Full Text] [Related]  

  • 33. Photodynamic mutagenic action of acridine compounds on yeast Saccharomyces cerevisiae.
    Iwamoto Y; Mifuchi I; Yielding LW
    Mutat Res; 1985 Dec; 158(3):169-75. PubMed ID: 3908930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of Salmonella typhi using resistotyping.
    Somerville PC; Nhlapo WM; Alberts M
    J Appl Bacteriol; 1983 Apr; 54(2):171-6. PubMed ID: 6853395
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural and functional alterations of catalase induced by acriflavine, a compound causing apoptosis and necrosis.
    Attar F; Khavari-Nejad S; Keyhani J; Keyhani E
    Ann N Y Acad Sci; 2009 Aug; 1171():292-9. PubMed ID: 19723068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acriflavine-mediated apoptosis and necrosis in yeast Candida utilis.
    Keyhani E; Khavari-Nejad S; Keyhani J; Attar F
    Ann N Y Acad Sci; 2009 Aug; 1171():284-91. PubMed ID: 19723067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of thrombin and heparin. Proflavine dye binding studies.
    Li EH; Orton C; Feinman RD
    Biochemistry; 1974 Nov; 13(24):5012-7. PubMed ID: 4373048
    [No Abstract]   [Full Text] [Related]  

  • 38. A Note on the Value of Brilliant Green as an Antiseptic.
    Webb CH
    Br Med J; 1917 Jun; 1(2948):870. PubMed ID: 20768638
    [No Abstract]   [Full Text] [Related]  

  • 39. BRILLIANT-GREEN AS AN ANTISEPTIC.
    Leitch A
    Br Med J; 1916 Feb; 1(2876):236-7. PubMed ID: 20768011
    [No Abstract]   [Full Text] [Related]  

  • 40. BRILLIANT GREEN: A CLINICAL STUDY OF ITS VALUE AS A LOCAL ANTISEPTIC.
    Narat JK
    Ann Surg; 1931 Dec; 94(6):1007-12. PubMed ID: 17866691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.